1Yagui K, Shimada F, Mimura M, et al. A missense mutation in the CD38 gene, a novel fact for insulin secretion:association with type 2 diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro. Diabetologia, 1998,41:1
2Kato I, Yamamoto Y, Fujimura M, et al. CD38( ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase ) disruption impairs glucose-induced increase in cyclic ADP-ribose, [ Ca2 + ] I, and insulin secretion. J Biol Chem, 1999,274:1869-1872.
3Mallone R, Ortolan E, Pinach S, et al. Anti-CD38 autoantibodies:characterization in new-onset type 1 diabetes and latent autoimmune diabetes of the adult(LADA)and comparison with other islet autoantibodies. Diabetes,2002,45:1667-1677.
4Ikehata F, Satoh J, Nata K, et al. Autoantibodies against CD38(ADPribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin-dependent diabetes patients. J Clin Invest, 1998,102: 395-401.
5Antonelli A, Tuomi T, Nannipieri M, et al. Autoimmunity to CD38 and GAD in type 1 and type 2 diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetes,2002,45:1298-1236.
6Marchetti P, Antonelli A, Lupi R, et al. Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets. Diabetes, 2002,51 (Suppl 3) :S474-S477.
7Ferrero E, Saccucci F, Malavasi F, et al. The human CD38 gene:polymorphism, CpG island and linkage to the CD157(BST-1)gene. Immunogenetics, 1999,49: 597-604.
8Fernandez J E, Deaglio S, Donati D, et al. Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. J Biol Regul Homeost Agents, 1998,12: 81-91.
9Funaro A, Malavasi F. Human CD38, a surface receptor, an enzyme,an adhesive molecule and not a simple marker. J Biol Regul Homeost Agents, 1999,13: 54-61.
10Mallone R, Ortolan E, Baj G, et al. Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes. Immunological and genetic characterization. Diabetes,2001,50:752-762.
4Brownsey RW, Boone AN, Elliott JE, et al. Regulation of acetyl-CoA carboxylase [J]. Biochem Soc Trans,2006,34(Pt 2):223-227.
5Targonsky ED, Dai F, Koshkin V, et al. Alpha-lipoic acid regulates AMP- activated protein kinase and inhibits insulin secretion from beta cells [J]. Diabetologia,2006,49(7): 1587-1598.
6Kusunoki J, Kanatani A, Moiler DE, et al. Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome [J]. Endocrine,2006,29(11):91-100.
7Roepstorff C, Halberg N, Hillig T, et al. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise [J]. Am J Physiol Endoerinol Metab,2005,288(3):E133-E142.
8Chen ZP, Stephens TJ, Murthy S, et al. Effect of exercise intensity on skeletal muscle AMPK signaling in humans [J]. Diabetes,2003,52(5): 2205-2212.
